RxDoctor Payments Data

Odette Fisher-Glover

Family · Columbia, SCNPI 1053398792

Payments from drug & device makers

$2,236in general payments, 2019–2025

Across 130 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$348
  • AbbVie$299
  • Lilly USA, LLC$208
  • AstraZeneca$200
  • Amgen$93
  • Esperion Therapeutics, Inc.$87
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,236100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,236 in reported general payments places this provider in the 80th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin13$22,598
EliquisApixaban19$22,451
KerendiaFinerenone25$18,832
TradjentaLinagliptin12$15,626
XareltoRivaroxaban15$14,889
SymbicortBudesonide/Formoterol Fumarate17$4,691
Atorvastatin Calcium66$516
Gabapentin23$437
Fluticasone Propionate24$392
Losartan Potassium44$362
Omeprazole37$359
Lisinopril28$317
Metformin Hcl ErMetformin Hcl24$300
Diclofenac Sodium13$261
Amlodipine Besylate51$241

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$73$38,22325 claims
PfizerEliquis$67$22,45119 claims
BayerKerendia$45$18,83225 claims
Johnson & JohnsonXarelto$82$14,88915 claims
AstraZenecaSymbicort$200$4,69117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,248 family providers in South Carolina.

Other family in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →